SHELDON H. PRESKORN, MD, is Professor and Chairman, Department of Psychiatry, University of Kansas School of Medicine-Wichita, and Chief Executive Officer and Medical Director, Clinical Research Institute, Wichita, Kansas. He has more than 25 years of drug development research experience at all levels (i.e., preclinical through Phase IV) and has been a principal investigator on over 175 clinical trials including every antidepressant marketed in the United States over the last 15 years. Dr. Preskorn maintains a website at where readers can access previous columns and other publications.
No takes yet. Share an insight, caveat, or question.
Sheldon Preskorn (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: